Tygh Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tygh Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-179,634	Closed	-$3.56M	–	104
2015 Q3	$3.56M	Sell	179,634 -189,987	-51%	-$6M	0.84%	54
2015 Q2	$12.8M	Sell	369,621 -81,982	-18%	-$2.5M	2.3%	1
2015 Q1	$11.7M	Buy	451,603 +56,773	+14%	+$1.04M	2.16%	3
2014 Q4	$5.09M	Buy	394,830 +85,367	+28%	+$1.07M	0.98%	47
2014 Q3	$3.8M	Buy	309,463 +64,989	+27%	+$755K	0.83%	58
2014 Q2	$3.87M	Buy	244,474 +115,489	+90%	+$1.65M	0.82%	55
2014 Q1	$1.95M	Buy	+128,985	New	+$1.46M	0.4%	90

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tygh Capital Management's HZNP Position: Q4 2015 in Review

Tygh Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2015, closing a stake of 179,634 shares — an estimated $3.56M sold.

Tygh Capital Management first reported a position in HZNP in Q1 2014 and held it in 7 quarters. The position peaked at $12.8M in Q2 2015. 202 funds tracked by Wall St. Rank hold HZNP as of Q4 2015.

Tygh Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2015 after selling out during the quarter.
Tygh Capital Management sold 179,634 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2015, an estimated $3.56M.
Tygh Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 7 quarters.
Tygh Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12.8M in Q2 2015.
202 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2015.

Based on Tygh Capital Management's 13F filing for Q4 2015, filed 2 Feb 2016.